M. Kuzma

发表

Tyrosine Kinase Inhibitors Reduce Glucose Uptake by Binding to an Exofacial Site on hGLUT‐1: Influence on 18F‐FDG PET Uptake

J. Tuszynski, J. Preto, M. Sawyer, 2020, Clinical and translational science.

Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.

Stephen A Baldwin, C. Cass, S. Baldwin, 2009, American journal of physiology. Renal physiology.

Human concentrative nucleoside transporter 3 is a determinant of fludarabine transportability and cytotoxicity in human renal proximal tubule cell cultures

C. Cass, S. Baldwin, M. Sawyer, 2008, Cancer Chemotherapy and Pharmacology.

Multitargeted kinase inhibitors imatinib, sorafenib and sunitinib perturb energy metabolism and cause cytotoxicity to cultured C2C12 skeletal muscle derived myotubes

C. Cass, M. Sawyer, C. Putman, 2018, Biochemical pharmacology.

Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.

C. Cass, M. Sawyer, R. Berendt, 2008, Biochemical pharmacology.

A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.

J. Mackey, C. Cass, M. Sawyer, 2016, Clinical breast cancer.

An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity

L. Mccargar, J. Mackey, T. Reiman, 2010, Cancer Chemotherapy and Pharmacology.

Inhibition of sodium-independent and sodium-dependent nucleobase transport activities by tyrosine kinase inhibitors

C. Cass, M. Sawyer, V. Damaraju, 2015, Cancer Chemotherapy and Pharmacology.

Selective Inhibition of Human Equilibrative and Concentrative Nucleoside Transporters by BCR-ABL Kinase Inhibitors

C. Cass, M. Sawyer, V. Damaraju, 2016, The Journal of Biological Chemistry.

Advances in Bioresorbable Electronics and Uses in Biomedical Sensing

Jian Yang, Dingying Shan, Michelle Kuzma, 2020 .

Biomaterial‐Based Metabolic Regulation in Regenerative Engineering

Jian Yang, X. Bai, Chuying Ma, 2019, Advanced science.

Citrate‐Based Tannin‐Bridged Bone Composites for Lumbar Fusion

Jian Yang, X. Bai, Xinggui Tian, 2020, Advanced Functional Materials.

Interactions of Multitargeted Kinase Inhibitors and Nucleoside Drugs: Achilles Heel of Combination Therapy?

C. Cass, M. Sawyer, V. Damaraju, 2014, Molecular Cancer Therapeutics.

Comparative in vitro evaluation of transportability and toxicity of capecitabine and its metabolites in cells derived from normal human kidney and renal cancers.

C. Cass, M. Sawyer, V. Damaraju, 2013, Biochemistry and cell biology = Biochimie et biologie cellulaire.

Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity

Carol E. Cass, Michelle Kuzma, Anderson J. Ryan, 2013, Clinical Cancer Research.

Cancer Therapy : Preclinical Erlotinib , Ge fi tinib , and Vandetanib Inhibit HumanNucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity

C. Cass, M. Sawyer, A. Ryan, 2013 .

Uridine glucuronosyltransferase 2B7 pharmacogenetics predicts epirubicin clearance and myelosuppression.

J. Mackey, M. Sawyer, E. Pituskin, 2009, Journal of Clinical Oncology.

Development of a new equation to estimate creatinine clearance in cancer patients

M. Sawyer, V. Baracos, C. Butts, 2015, Cancer Chemotherapy and Pharmacology.

Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.

C. Cass, S. Baldwin, M. Sawyer, 2009, American journal of physiology. Renal physiology.

Erlotinib, Gefitinib, and Vandetanib Inhibit Human Nucleoside Transporters and Protect Cancer Cells from Gemcitabine Cytotoxicity

C. Cass, M. Sawyer, A. Ryan, 2013, Clinical Cancer Research.